Tag: bilirubin blood test market forecast

Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

Bilirubin Blood Test Market Revenue Outlook: What CAGR Lies Ahead Through 2030?

The bilirubin blood test market size has experienced robust growth over recent years. It is anticipated to expand from $1.46 billion in 2025 to $1.57 billion in 2026, registering a compound annual growth rate (CAGR) of 7.4%. This historical expansion can be linked to several factors, including the increase in neonatal jaundice screening programs, a rise in hospital-based liver function testing, enhanced diagnostic awareness of liver disorders, the regular integration of serum bilirubin testing into clinical practice, and the broader availability of pediatric and infant diagnostic services.

The bilirubin blood test market is anticipated to experience substantial growth in the upcoming years, projected to reach $2.08 billion in 2030 with a compound annual growth rate (CAGR) of 7.3%. This expansion during the forecast period is primarily driven by the increasing incidence of chronic liver disease and hepatitis, a heightened need for early assessment of liver health, and the growing application of bilirubin testing in primary care environments. Additionally, higher rates of testing among aging and at-risk patient groups, coupled with the advancement of point-of-care and specialized liver diagnostics, contribute to this trajectory. Major developments expected in this period include the wider use of bilirubin testing for evaluating liver function, its increasing adoption in screening for neonatal jaundice, and a rising demand for such tests in hematology and for preliminary liver disorder assessments. Furthermore, there will be an expansion of bilirubin monitoring across various hospital and clinical settings, emphasizing proactive detection and routine screening for maintaining liver health.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=57935499&type=smp&name=Bilirubin%20Blood%20Test%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Sep_PR

Bilirubin Blood Test Market Development Factors: What’s Supporting Demand?

The increasing occurrence of liver conditions is anticipated to drive expansion in the bilirubin blood test market moving forward. Liver ailments encompass various conditions that hinder the liver’s proper functioning, potentially stemming from factors like infections, excessive alcohol consumption, or metabolic issues. The surge in liver disease cases is linked to higher rates of obesity, heavy alcohol intake, viral pathogens, and poor lifestyle decisions, all of which contribute to liver impairment and harm. Liver conditions can markedly affect the body’s bilirubin levels, with bilirubin blood tests assisting in diagnosing and tracking liver function. These tests offer vital information about patient health and support healthcare professionals in efficiently addressing and treating liver-associated issues. For example, data from GOV.UK, a UK department for science, innovation, and technology, showed that in April 2023, hospital admission rates for liver disease climbed from 150.6 (148.2–152.9) to 155.2 (152.9–157.5) per 100,000 population between the fiscal years concluding 2022 and 2023, highlighting a persistent rise in hospitalizations due to liver conditions. Consequently, the increasing prevalence of liver ailments is stimulating the bilirubin blood test market.

Bilirubin Blood Test Market Segment Analysis And Revenue Potential

The bilirubin blood test market covered in this report is segmented –

1) By Test Type: Total Serum Bilirubin Test, Indirect Or Unconjugated Bilirubin Test, Direct Or Conjugated Bilirubin Test

2) By Age Group: Adults, Pediatrics, Infants

3) By Application: Hospital, Clinic, Other Applications

Subsegments:

1) By Total Serum Bilirubin Test: Routine Screening, Liver Function Assessment, Newborn Jaundice Detection

2) By Indirect Or Unconjugated Bilirubin Test: Hemolytic Anemia Diagnosis, Gilbert’s Syndrome Detection, Monitoring For Preliver Conditions

3) By Direct Or Conjugated Bilirubin Test: Bile Duct Obstruction Diagnosis, Hepatitis And Liver Disease Monitoring, Post-Liver Condition Assessment

Bilirubin Blood Test Market Transformation Trends: What Innovations Are Driving Change?

Companies operating within the bilirubin blood test market are increasingly adopting strategic partnership approaches to expand their reach and enhance their service offerings. Such a strategic partnership typically denotes a collaborative relationship between two or more organizations that merge their resources, expertise, and efforts to achieve common goals or objectives. For instance, in December 2023, Calmark Sweden AB, an Israel-based company specializing in medical diagnostic biotechnology solutions, finalized an exclusive distributor agreement with Techno Orbits in Saudi Arabia for Calmark’s bilirubin test specifically designed for newborns. Techno Orbits will manage the distribution and sales of this product, leveraging its existing network and relationships, including those with the Ministry of Health. This alliance aims to facilitate the introduction of Calmark’s bilirubin test into the Saudi market, where regulatory registration is projected to take between 3 to 6 months.

Bilirubin Blood Test Market Competitive Landscape: Who Leads The Industry?

Major companies operating in the bilirubin blood test market are Abbott Laboratories, Thermo Fisher Scientific, F. Hoffmann‑La Roche Ltd, Siemens Healthineers, Danaher Corporation, Sysmex Corporation, Bio‑Rad Laboratories Inc, Ortho Clinical Diagnostics Inc, Mindray Medical International Limited, Randox Laboratories Ltd, bioMérieux SA, DiaSorin S.p.A, Horiba Ltd, ELITech Group SAS, Erba Mannheim, Hitachi High‑Technologies, DIRUI Industrial Co Ltd, Agappe Diagnostics, Awareness Technology Inc, Sekisui Diagnostics

View The Full Bilirubin Blood Test Market Report:

https://thebusinessresearchcompany.com/report/bilirubin-blood-test-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Sep_PR

Bilirubin Blood Test Market Geographic Landscape: Which Region Leads Industry Growth?

North America was the largest region in the bilirubin blood test market in 2025. The regions covered in the bilirubin blood test market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Forecasted Rise In Market Size Of The Bilirubin Blood Test Market During The Forecast Period?

The bilirubin blood test market size has demonstrated significant expansion in recent years. It is anticipated to expand from $1.46 billion in 2025 to $1.57 billion in 2026, advancing at a compound annual growth rate (CAGR) of 7.4%. The factors contributing to its historical development include an increase in neonatal jaundice screening programs, a rise in hospital-based liver function testing, heightened diagnostic awareness of liver disorders, the widespread adoption of serum bilirubin testing in routine clinical practice, and the expansion of pediatric and infant diagnostic services.

The bilirubin blood test market size is projected to experience substantial growth over the next few years, reaching $2.08 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.3%. This anticipated expansion during the forecast period is driven by factors such as the increasing prevalence of chronic liver disease and hepatitis, a rising need for early assessment of liver health, the expanded use of bilirubin testing in primary care settings, higher testing rates among aging and at-risk patient populations, and the broadening of point-of-care and specialty liver diagnostics. Key trends influencing the market include the increasing application of bilirubin testing for liver function assessment, the growing adoption of these tests in neonatal jaundice screening, an escalating demand for testing in hematology and the evaluation of pre-liver disorders, the wider implementation of bilirubin monitoring across hospital and clinical environments, and a concentrated focus on early detection and routine screening for optimal liver health.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18522&type=smp

Which Growth Drivers Are Expected To Support The Bilirubin Blood Test Market Forward?

The bilirubin blood test market is anticipated to expand going forward, driven by the increasing occurrence of liver diseases. Liver diseases refer to a variety of conditions that hinder the liver’s proper functioning, potentially stemming from factors such as infections, alcohol abuse, or metabolic disorders. The growing number of liver disease cases is linked to rising rates of obesity, excessive alcohol consumption, viral infections, and unhealthy lifestyle choices, which collectively contribute to liver dysfunction and damage. Liver conditions can significantly affect bilirubin levels in the body, and bilirubin blood tests are instrumental in diagnosing and monitoring liver function, offering crucial insights into patient health and assisting healthcare providers in effectively managing and treating liver-related conditions. For instance, in April 2023, according to GOV.UK, a UK-based department for science, innovation, and technology, hospital admission rates for liver disease rose from 150.6 (148.2–152.9) to 155.2 (152.9–157.5) per 100,000 population between the financial years ending 2022 and 2023, highlighting a continuous upward trend in liver disease-related hospitalizations. Therefore, the growing incidences of liver diseases are propelling the bilirubin blood test market.

What Segment Types Are Included In The Bilirubin Blood Test Market Analysis?

The bilirubin blood test market covered in this report is segmented –

1) By Test Type: Total Serum Bilirubin Test, Indirect Or Unconjugated Bilirubin Test, Direct Or Conjugated Bilirubin Test

2) By Age Group: Adults, Pediatrics, Infants

3) By Application: Hospital, Clinic, Other Applications

Subsegments:

1) By Total Serum Bilirubin Test: Routine Screening, Liver Function Assessment, Newborn Jaundice Detection

2) By Indirect Or Unconjugated Bilirubin Test: Hemolytic Anemia Diagnosis, Gilbert’s Syndrome Detection, Monitoring For Preliver Conditions

3) By Direct Or Conjugated Bilirubin Test: Bile Duct Obstruction Diagnosis, Hepatitis And Liver Disease Monitoring, Post-Liver Condition Assessment

Which Trends Are Shaping The Bilirubin Blood Test Market Landscape?

Leading entities within the bilirubin blood test market are embracing strategic alliances to broaden their market penetration and enrich their service portfolios. Such a partnership generally signifies a cooperative arrangement between multiple organizations that merge their resources, specialized knowledge, and endeavors to accomplish shared aims. As an illustration, in December 2023, Calmark Sweden AB, a medical diagnostic biotechnology solutions firm based in Israel, entered into an exclusive distributorship pact with Techno Orbits in Saudi Arabia specifically for Calmark’s bilirubin test intended for infants. Techno Orbits is set to manage the product’s distribution and sales, utilizing its established network and connections, which encompass those with the Ministry of Health. The objective of this collaboration is to smooth the entry of Calmark’s bilirubin test into the Saudi market, where the regulatory registration process is anticipated to require 3 to 6 months.

Which Organizations Are Involved In The Bilirubin Blood Test Market?

Major companies operating in the bilirubin blood test market are Abbott Laboratories, Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd, Siemens Healthineers, Danaher Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc, Ortho Clinical Diagnostics Inc, Mindray Medical International Limited, Randox Laboratories Ltd, bioMérieux SA, DiaSorin S.p.A, Horiba Ltd, ELITech Group SAS, Erba Mannheim, Hitachi High-Technologies, DIRUI Industrial Co Ltd, Agappe Diagnostics, Awareness Technology Inc, Sekisui Diagnostics

Access The Complete Bilirubin Blood Test Market Report:

https://www.thebusinessresearchcompany.com/report/bilirubin-blood-test-global-market-report

Which Region Has The Strongest Presence In The Bilirubin Blood Test Market?

North America was the largest region in the bilirubin blood test market in 2025. The regions covered in the bilirubin blood test market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Bilirubin Blood Test Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=18522&type=smp

Browse Through More Reports Similar to the Global Bilirubin Blood Test Market 2026, By The Business Research Company

Bilirubin Meters Market Report 2026

https://www.thebusinessresearchcompany.com/report/bilirubin-meters-global-market-report

Hemoglobin Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemoglobin-testing-global-market-report

Hemoglobin A1C Hba1C Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemoglobin-a1c-hba1c-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Anticipated Rise In Market Value Of The Bilirubin Blood Test Market During The Forecast Period?

The bilirubin blood test market has experienced strong growth in recent years. It is anticipated to increase from $1.46 billion in 2025 to $1.57 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.4%. The expansion observed in prior periods can be attributed to the rise in neonatal jaundice screening programs, an increase in hospital-based liver function testing, greater diagnostic awareness of liver disorders, the adoption of serum bilirubin testing in standard clinical practice, and the expansion of pediatric and infant diagnostic services.

The bilirubin blood test market size is anticipated to demonstrate robust growth over the next few years, with projections indicating an increase to $2.08 billion by 2030, reflecting a compound annual growth rate (CAGR) of 7.3%. This expansion during the forecast period is attributable to the increasing incidence of chronic liver disease and hepatitis, a heightened demand for early assessment of liver health, the growing integration of bilirubin testing into primary care settings, increased testing rates among aging and at-risk patient populations, and the advancement of point-of-care and specialized liver diagnostics. Significant trends during this period encompass a rising utilization of bilirubin testing for evaluating liver function, the increasing adoption of bilirubin tests in neonatal jaundice screening programs, an escalating demand for testing in hematology and preliminary liver disorder evaluations, the broader implementation of bilirubin monitoring across hospital and clinical environments, and an intensified focus on early detection and routine screening for optimal liver health.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18522&type=smp

What Leading Drivers Are Supporting The Bilirubin Blood Test Market Expansion?

The increasing occurrence of liver ailments is anticipated to drive the expansion of the bilirubin blood test market in the future. Liver conditions encompass diverse health issues that hinder the liver’s proper functioning, stemming from factors like infections, excessive alcohol intake, or metabolic imbalances. This surge in liver disease cases is linked to higher rates of obesity, heavy alcohol use, viral infections, and poor lifestyle choices, all of which contribute to impaired liver function and damage. Liver ailments can notably affect bilirubin levels within the body, and bilirubin blood tests are instrumental in diagnosing and monitoring liver function, offering vital information about patient health and assisting medical professionals in the effective management and treatment of liver-related issues. An example illustrates this trend: in April 2023, data from GOV.UK, a UK-based department for science, innovation, and technology, showed that hospital admissions for liver disease rose from 150.6 (148.2–152.9) to 155.2 (152.9–157.5) per 100,000 population during the financial years ending 2022 and 2023, highlighting an ongoing increase in hospitalizations due to liver conditions. Consequently, the rising prevalence of liver diseases is a key factor propelling the bilirubin blood test market.

How Is Segmentation Applied In The Bilirubin Blood Test Market Segment Analysis?

The bilirubin blood test market covered in this report is segmented –

1) By Test Type: Total Serum Bilirubin Test, Indirect Or Unconjugated Bilirubin Test, Direct Or Conjugated Bilirubin Test

2) By Age Group: Adults, Pediatrics, Infants

3) By Application: Hospital, Clinic, Other Applications

Subsegments:

1) By Total Serum Bilirubin Test: Routine Screening, Liver Function Assessment, Newborn Jaundice Detection

2) By Indirect Or Unconjugated Bilirubin Test: Hemolytic Anemia Diagnosis, Gilbert’s Syndrome Detection, Monitoring For Preliver Conditions

3) By Direct Or Conjugated Bilirubin Test: Bile Duct Obstruction Diagnosis, Hepatitis And Liver Disease Monitoring, Post-Liver Condition Assessment

What Emerging Trends Are Seen In The Bilirubin Blood Test Market?

Leading firms within the bilirubin blood test market are increasingly utilizing strategic collaborations as a method to broaden their market presence and improve their service provisions. Such a partnership generally involves a cooperative arrangement between multiple entities, pooling their assets, specialized knowledge, and collective endeavors to attain shared aims or targets. An example occurred in December 2023 when Calmark Sweden AB, a medical diagnostic biotechnology firm from Israel, entered into an exclusive distribution pact with Techno Orbits in Saudi Arabia, specifically for Calmark’s bilirubin test intended for newborns. Techno Orbits is slated to manage the product’s distribution and sales, utilizing its established network and connections, which extend to the Ministry of Health. The goal of this alliance is to smooth the entry of Calmark’s bilirubin test into the Saudi market, anticipating that regulatory approval will require 3 to 6 months.

Who Are The Companies Participating In The Bilirubin Blood Test Market Environment?

Major companies operating in the bilirubin blood test market are Abbott Laboratories, Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd, Siemens Healthineers, Danaher Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc, Ortho Clinical Diagnostics Inc, Mindray Medical International Limited, Randox Laboratories Ltd, bioMérieux SA, DiaSorin S.p.A, Horiba Ltd, ELITech Group SAS, Erba Mannheim, Hitachi High-Technologies, DIRUI Industrial Co Ltd, Agappe Diagnostics, Awareness Technology Inc, Sekisui Diagnostics

Get The Full Bilirubin Blood Test Market Report:

https://www.thebusinessresearchcompany.com/report/bilirubin-blood-test-global-market-report

Which Region Is The Leading Market For The Bilirubin Blood Test Market?

North America was the largest region in the bilirubin blood test market in 2025. The regions covered in the bilirubin blood test market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Bilirubin Blood Test Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=18522&type=smp

Browse Through More Reports Similar to the Global Bilirubin Blood Test Market 2026, By The Business Research Company

Bilirubin Meters Market Report 2026

https://www.thebusinessresearchcompany.com/report/bilirubin-meters-global-market-report

Hemoglobin Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemoglobin-testing-global-market-report

Hemoglobin A1C Hba1C Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemoglobin-a1c-hba1c-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Will Be The Estimated Market Valuation Of The Bilirubin Blood Test Market By The End Of 2030?

The bilirubin blood test market has experienced substantial growth in recent years. It is anticipated to expand from $1.46 billion in 2025 to $1.57 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.4%. This historical expansion is largely due to factors such as an increase in neonatal jaundice screening programs, a rise in hospital-based liver function testing, enhanced diagnostic awareness regarding liver disorders, the integration of serum bilirubin testing into routine clinical practice, and the broadening of pediatric and infant diagnostic services.

The bilirubin blood test market is anticipated to experience substantial expansion in the coming years, with its size projected to reach $2.08 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 7.3%. This expansion during the forecast period is driven by factors such as the increasing incidence of chronic liver disease and hepatitis, a growing demand for early assessment of liver health, the rising adoption of bilirubin testing in primary care environments, higher rates of testing among aging and high-risk patient populations, and the proliferation of point-of-care and specialized liver diagnostics. Significant trends expected during this period include an intensified application of bilirubin testing for evaluating liver function, the expanding use of bilirubin tests in screening for neonatal jaundice, an increased requirement for testing in hematology and pre-liver disorder evaluations, the broader deployment of bilirubin monitoring across hospital and clinical settings, and a strategic focus on early detection and routine screening for liver wellness.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18522&type=smp

What Drivers Are Shaping The Future Growth Of The Bilirubin Blood Test Market?

The escalating prevalence of liver diseases is projected to drive the expansion of the bilirubin blood test market in the future. Liver diseases encompass a spectrum of conditions that compromise the liver’s proper functioning, potentially arising from various factors such as infections, alcohol abuse, or metabolic disorders. The increasing incidence of liver disease cases can be attributed to rising rates of obesity, excessive alcohol consumption, viral infections, and unhealthy lifestyle choices, which collectively contribute to liver dysfunction and damage. Such conditions can significantly affect bilirubin levels within the body, and bilirubin blood tests are instrumental in diagnosing and monitoring liver function, thereby offering crucial insights into patient health and assisting healthcare providers in the effective management and treatment of liver-related conditions. For instance, in April 2023, according to GOV.UK, a UK-based department for science, innovation, and technology, hospital admission rates for liver disease increased from 150.6 (148.2–152.9) to 155.2 (152.9–157.5) per 100,000 population between the financial years ending 2022 and 2023, underscoring a continued upward trend in liver disease-related hospitalizations. Hence, the increasing occurrences of liver diseases are a significant driver for the bilirubin blood test market.

Which Segment Classifications Shape The Bilirubin Blood Test Market?

The bilirubin blood test market covered in this report is segmented –

1) By Test Type: Total Serum Bilirubin Test, Indirect Or Unconjugated Bilirubin Test, Direct Or Conjugated Bilirubin Test

2) By Age Group: Adults, Pediatrics, Infants

3) By Application: Hospital, Clinic, Other Applications

Subsegments:

1) By Total Serum Bilirubin Test: Routine Screening, Liver Function Assessment, Newborn Jaundice Detection

2) By Indirect Or Unconjugated Bilirubin Test: Hemolytic Anemia Diagnosis, Gilbert’s Syndrome Detection, Monitoring For Preliver Conditions

3) By Direct Or Conjugated Bilirubin Test: Bile Duct Obstruction Diagnosis, Hepatitis And Liver Disease Monitoring, Post-Liver Condition Assessment

How Are Trends Impacting The Bilirubin Blood Test Market?

Leading firms within the bilirubin blood test market are employing a strategic partnership strategy to broaden their market presence and augment their service portfolio. Such a partnership generally denotes a cooperative arrangement involving two or more entities pooling their resources, knowledge, and endeavors to reach shared aims or targets. As an illustration, Calmark Sweden AB, a medical diagnostic biotechnology solutions company based in Israel, entered into an exclusive distributor agreement with Techno Orbits in Saudi Arabia in December 2023, specifically for Calmark’s bilirubin test intended for newborns. Techno Orbits is set to manage the product’s distribution and sales, utilizing its established network and connections, including those with the Ministry of Health. The objective of this collaboration is to streamline the entry of Calmark’s bilirubin test into the Saudi market, with regulatory registration projected to conclude within 3 to 6 months.

Which Companies Are Expanding Their Footprint In The Bilirubin Blood Test Market?

Major companies operating in the bilirubin blood test market are Abbott Laboratories, Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd, Siemens Healthineers, Danaher Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc, Ortho Clinical Diagnostics Inc, Mindray Medical International Limited, Randox Laboratories Ltd, bioMérieux SA, DiaSorin S.p.A, Horiba Ltd, ELITech Group SAS, Erba Mannheim, Hitachi High-Technologies, DIRUI Industrial Co Ltd, Agappe Diagnostics, Awareness Technology Inc, Sekisui Diagnostics

Read the full bilirubin blood test market report here:

https://www.thebusinessresearchcompany.com/report/bilirubin-blood-test-global-market-report

Which Geographic Regions Are Influencing Demand In The Bilirubin Blood Test Market?

North America was the largest region in the bilirubin blood test market in 2025. The regions covered in the bilirubin blood test market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Bilirubin Blood Test Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=18522&type=smp

Browse Through More Reports Similar to the Global Bilirubin Blood Test Market 2026, By The Business Research Company

Bilirubin Meters Market Report 2026

https://www.thebusinessresearchcompany.com/report/bilirubin-meters-global-market-report

Hemoglobin Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemoglobin-testing-global-market-report

Hemoglobin A1C Hba1C Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemoglobin-a1c-hba1c-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the medical release liner market from 2026–2035 with trusted insights from The Business Research Company

Starting from its 2026 valuation, what market size is the Bilirubin Blood Test Market expected to reach by 2030?

The bilirubin blood test market size has experienced robust growth over recent years. Its value is anticipated to rise from $1.46 billion in 2025 to $1.57 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.4%. This historical expansion can be attributed to several factors including an increase in neonatal jaundice screening programs, a rise in hospital-based liver function testing, enhanced diagnostic awareness of liver disorders, the mainstream adoption of serum bilirubin testing in routine clinical practice, and the expansion of pediatric and infant diagnostic services.

The bilirubin blood test market size is anticipated to experience substantial expansion in the coming years. This market is projected to reach $2.08 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.3%. Factors contributing to this growth during the forecast period include the increasing prevalence of chronic liver disease and hepatitis, a growing need for early evaluation of liver health, the expanded use of bilirubin testing in primary care, elevated testing rates among elderly and vulnerable patient groups, and the spread of point-of-care and specialized liver diagnostic solutions. Key trends expected over the forecast period encompass a greater reliance on bilirubin testing for assessing liver function, the wider uptake of bilirubin tests for neonatal jaundice screening, an increasing need for testing in hematology and for evaluating pre-liver disorders, the broader implementation of bilirubin monitoring in hospitals and clinical environments, and an emphasis on early detection and regular screening for liver well-being.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18522&type=smp

What Drivers Are Driving Adoption Within The Bilirubin Blood Test Market?

The expanding prevalence of liver ailments is anticipated to boost the bilirubin blood test market moving forward. Liver ailments encompass various conditions that hinder the liver’s proper functioning, stemming from factors such as infections, heavy alcohol use, or metabolic issues. The increasing frequency of liver disease occurrences is linked to a rise in obesity, excessive alcohol intake, viral infections, and poor lifestyle choices, all contributing to liver damage and dysfunction. Liver conditions can significantly alter bilirubin levels in the body, and bilirubin blood tests are instrumental in diagnosing and monitoring liver function, offering vital information on patient health and assisting healthcare providers in effectively addressing and treating liver-related problems. For instance, in April 2023, data from GOV.UK, a UK-based department for science, innovation, and technology, indicated that hospital admission rates for liver disease rose from 150.6 (148.2–152.9) to 155.2 (152.9–157.5) per 100,000 population during the financial years ending 2022 and 2023, highlighting a persistent increase in liver disease-related hospitalizations. Consequently, the rising instances of liver diseases are stimulating the bilirubin blood test market.

How Is The Bilirubin Blood Test Market Organized Into Various Segments?

The bilirubin blood test market covered in this report is segmented –

1) By Test Type: Total Serum Bilirubin Test, Indirect Or Unconjugated Bilirubin Test, Direct Or Conjugated Bilirubin Test

2) By Age Group: Adults, Pediatrics, Infants

3) By Application: Hospital, Clinic, Other Applications

Subsegments:

1) By Total Serum Bilirubin Test: Routine Screening, Liver Function Assessment, Newborn Jaundice Detection

2) By Indirect Or Unconjugated Bilirubin Test: Hemolytic Anemia Diagnosis, Gilbert’s Syndrome Detection, Monitoring For Preliver Conditions

3) By Direct Or Conjugated Bilirubin Test: Bile Duct Obstruction Diagnosis, Hepatitis And Liver Disease Monitoring, Post-Liver Condition Assessment

Which Innovation Trends Are Advancing Developments Within The Bilirubin Blood Test Market?

Leading companies operating within the bilirubin blood test market are employing a strategic partnership approach to expand their market reach and improve their service offerings. A strategic partnership generally refers to a collaborative relationship between two or more entities where they combine their resources, specialized knowledge, and efforts to accomplish shared objectives or goals. For example, in December 2023, Calmark Sweden AB, an Israel-based company specializing in medical diagnostic biotechnology solutions, finalized an exclusive distributor agreement with Techno Orbits in Saudi Arabia for Calmark’s bilirubin test intended for newborns. Techno Orbits will manage the distribution and sales of the product, leveraging its established network and relationships, including those with the Ministry of Health. This alliance seeks to enable the entry of Calmark’s bilirubin test into the Saudi market, with regulatory registration expected to conclude within 3 to 6 months.

Who Are The Core Companies Influencing Trends In The Bilirubin Blood Test Market?

Major companies operating in the bilirubin blood test market are Abbott Laboratories, Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd, Siemens Healthineers, Danaher Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc, Ortho Clinical Diagnostics Inc, Mindray Medical International Limited, Randox Laboratories Ltd, bioMérieux SA, DiaSorin S.p.A, Horiba Ltd, ELITech Group SAS, Erba Mannheim, Hitachi High-Technologies, DIRUI Industrial Co Ltd, Agappe Diagnostics, Awareness Technology Inc, Sekisui Diagnostics

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/bilirubin-blood-test-global-market-report

Which Regions Are Projected To Dominate The Bilirubin Blood Test Market In The Coming Years?

North America was the largest region in the bilirubin blood test market in 2025. The regions covered in the bilirubin blood test market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Bilirubin Blood Test Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=18522&type=smp

Browse Through More Reports Similar to the Global Bilirubin Blood Test Market 2026, By The Business Research Company

Bilirubin Meters Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/bilirubin-meters-global-market-report

Hemoglobin Testing Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemoglobin-testing-global-market-report

Hemoglobin A1C Hba1C Testing Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemoglobin-a1c-hba1c-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Uncover key drivers, emerging technologies, and competitive movements shaping the bilirubin blood test market from 2025–2034 with trusted insights from The Business Research Company

How Is The Bilirubin Blood Test Market Size Expected To Expand Over 2029-2034?

The market for bilirubin blood tests has demonstrated significant expansion in recent years. This market is anticipated to rise from $1.37 billion in 2024 to $1.46 billion in 2025, achieving a compound annual growth rate (CAGR) of 6.9%. The factors contributing to its historical growth include the escalating prevalence of liver diseases, advancements in neonatal care, technological innovations, increased health awareness, improvements in healthcare infrastructure development, the issuance of regulatory approvals and guidelines, and the greater adoption of point-of-care testing.

The bilirubin blood test market size is anticipated to undergo significant expansion in the coming years, with projections indicating a growth to $1.94 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 7.4%. This prospective growth is attributed to factors such as an increasing demand for early diagnosis, the expansion of diagnostic laboratories, a rising prevalence of chronic diseases, the development of emerging markets, the incorporation of advanced analytics, and an increase in research funding. Prominent trends expected during this forecast period encompass the evolution of non-invasive testing methods, their integration with digital health solutions, advancements in home testing kits, improvements in test accuracy and speed, the adoption of personalized medicine approaches, the emergence of smart diagnostic devices, and the creation of portable diagnostic tools.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18522&type=smp

Which Market Factors Are Fueling The Bilirubin Blood Test Industry Growth?

The increasing incidences of liver diseases are projected to drive the growth of the bilirubin blood test market in the future. Liver diseases involve a variety of conditions that hinder the liver’s proper operation, potentially caused by infections, alcohol abuse, or metabolic disorders. The rising number of liver disease cases is attributable to increasing rates of obesity, excessive alcohol consumption, viral infections, and unhealthy lifestyle choices, which collectively lead to liver dysfunction and damage. Liver disease significantly impacts bilirubin levels in the body, and bilirubin blood tests are crucial for diagnosing and monitoring liver function, offering vital insights into patient health and assisting healthcare providers in effectively managing and treating liver-related conditions. For instance, in April 2024, according to the European Centre for Disease Prevention and Control, a Sweden-based government health agency, there were 28,855 recorded cases of hepatitis B virus (HBV) infection across 30 EU/EEA Member States in 2022, an increase of 78% compared to 16,187 cases in 2021. Additionally, the number of cases in 2022, totaling 28,420, represents a crude rate of 8.5 cases per 100,000 people. Therefore, the growing incidences of liver diseases are a significant driver for the bilirubin blood test market.

Which Categories Are Covered In The Bilirubin Blood Test Market Segmentation Analysis?

The bilirubin blood testmarket covered in this report is segmented –

1) By Test Type: Total Serum Bilirubin Test, Indirect Or Unconjugated Bilirubin Test, Direct Or Conjugated Bilirubin Test

2) By Age Group: Adults, Pediatrics, Infants

3) By Application: Hospital, Clinic, Other Applications

Subsegments:

1) By Total Serum Bilirubin Test: Routine Screening, Liver Function Assessment, Newborn Jaundice Detection

2) By Indirect Or Unconjugated Bilirubin Test: Hemolytic Anemia Diagnosis, Gilbert’s Syndrome Detection, Monitoring For Preliver Conditions

3) By Direct Or Conjugated Bilirubin Test: Bile Duct Obstruction Diagnosis, Hepatitis And Liver Disease Monitoring, Post-Liver Condition Assessment

Which Market Trends Are Expected To Define The Future Of The Bilirubin Blood Test Market?

Companies operating significantly within the bilirubin blood test market are adopting a strategic partnership strategy to expand their reach and enhance their service offerings. A strategic partnership typically denotes a collaborative relationship between two or more organizations where they combine their resources, expertise, and efforts to achieve common goals or objectives. For instance, in December 2023, Calmark Sweden AB, an Israel-based medical diagnostic biotechnology solutions company, entered into an exclusive distributor agreement with Techno Orbits in Saudi Arabia for Calmark’s bilirubin test designed for newborns. Techno Orbits will manage the distribution and sales of the product, utilizing its established network and relationships, including those with the Ministry of Health. This partnership intends to facilitate the introduction of Calmark’s bilirubin test into the Saudi market, where regulatory registration is projected to take 3 to 6 months.

Which Organizations Are At The Forefront Of The Bilirubin Blood Test Market?

Major companies operating in the bilirubin blood test market are F.Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Koninklijke Philips N.V., Mindray Medical International Limited, Beckman Coulter Inc., Drägerwerk AG and Co. KGaA, Sysmex Corporation, Bio-Rad Laboratories Inc., Konica Minolta Inc., Instrumentation Laboratory LLC, Randox Laboratories Ltd., Ortho Clinical Diagnostics Inc., Natus Medical Incorporated, Nova Biomedical, Advanced Instruments LLC, Helmer Scientific Inc., Reichert Technologies Inc., Rousselet Robatel SAS, Labnet International Inc., AVI Healthcare Pvt. Ltd., Ginevri S.p.A.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/bilirubin-blood-test-global-market-report

Which Geographic Areas Are Driving Strong Demand For The Bilirubin Blood Test Market?

North America was the largest region in the bilirubin blood test market in 2024. The regions covered in the bilirubin blood test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=18522&type=smp

Browse Through More Reports Similar to the Global Bilirubin Blood Test Market 2025, By The Business Research Company

Anemia And Other Blood Disorder Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/anemia-and-other-blood-disorder-drugs-global-market-report

Blood Transfusion Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report

Stem Cell Cord Blood Banking Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/stem-cell-cord-blood-banking-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Growth Projections For The Bilirubin Blood Test Market Size During 2025–2029?

The overall valuation of the bilirubin blood test sector has experienced robust expansion over the recent past, projected to ascend from its 2024 figure of $1.37 billion to reach $1.46 billion in 2025, reflecting a compound annual growth rate of 6.9%. This upward trajectory during the historical timeframe stems from several key factors, including the rising incidence of hepatic ailments, expansion within neonatal assistance services, progress in diagnostic technology, heightened public consciousness regarding health matters, improvements in medical facilities, the establishment of official mandates and protocols, and a greater uptake of testing solutions situated at the point of patient care.

Anticipation surrounds the bilirubin blood test sector, projecting robust expansion over the forthcoming period, reaching a valuation of $1.94 billion by 2029, propelled by a compound annual growth rate (CAGR) of 7.4%; this upward trajectory is fueled by several key factors, including heightened needs for prompt disease identification, the proliferation of diagnostic facilities, an increase in the prevalence of long-term medical conditions, burgeoning opportunities within developing regions, the incorporation of sophisticated analytical tools, and increased financial support for research endeavors, while notable shifts in the market landscape feature the creation of testing procedures that preclude invasive techniques, the weaving together of testing with digital healthcare platforms, progress in self-administered testing kits, improvements in both the precision and quickness of test results, the adoption of tailored medical treatments, the rise of intelligent diagnostic instrumentation, and the engineering of easily transportable testing apparatus.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18522&type=smp

What Are The Top Growth Drivers Impacting The Bilirubin Blood Test Market Outlook?

Anticipated escalation in the prevalence of hepatic ailments is projected to fuel the expansion of the bilirubin blood testing sector moving ahead. Hepatic ailments encompass diverse conditions that compromise the organ’s appropriate operation, stemming from numerous origins like contagion, excessive alcohol use, or metabolic anomalies. The surge in recorded instances of liver affliction can be linked to escalating obesity statistics, heavy alcohol intake, viral contagions, and detrimental lifestyle patterns, all contributing to hepatic impairment and degradation. Since liver disease profoundly affects subsequent bilirubin concentrations within the organism, these blood assessments prove vital for both identifying and tracking hepatic performance, furnishing healthcare professionals with essential patient health data necessary for the successful administration and therapy of liver-associated problems. To illustrate this trend, data from the European Centre for Disease Prevention and Control, a governmental health body based in Sweden, revealed that for the year 2022, there were 28,855 documented occurrences of hepatitis B virus (HBV) infection reported across 30 EU/EEA Member States, marking a substantial 78 percent rise from the 16,187 cases noted in 2021; moreover, the 28,420 total cases recorded in 2022 translate to an unadjusted incidence rate of 8.5 infections per 100,000 residents, underscoring how the increasing frequency of liver issues is stimulating demand within the bilirubin blood test market.

What Are The Emerging Segments Gaining Attention In The Bilirubin Blood Test Market?

The bilirubin blood testmarket covered in this report is segmented –

1) By Test Type: Total Serum Bilirubin Test, Indirect Or Unconjugated Bilirubin Test, Direct Or Conjugated Bilirubin Test

2) By Age Group: Adults, Pediatrics, Infants

3) By Application: Hospital, Clinic, Other Applications

Subsegments:

1) By Total Serum Bilirubin Test: Routine Screening, Liver Function Assessment, Newborn Jaundice Detection

2) By Indirect Or Unconjugated Bilirubin Test: Hemolytic Anemia Diagnosis, Gilbert’s Syndrome Detection, Monitoring For Preliver Conditions

3) By Direct Or Conjugated Bilirubin Test: Bile Duct Obstruction Diagnosis, Hepatitis And Liver Disease Monitoring, Post-Liver Condition Assessment

What Long-Term Trends Will Shape The Future Growth Of The Bilirubin Blood Test Industry?

Leading firms within the bilirubin blood test sector are increasingly favoring a strategy of forming alliances to broaden their presence and augment the services they provide. This kind of strategic alliance essentially describes a cooperative venture among several entities, pooling their assets, specialized knowledge, and work to meet shared aims. As a concrete illustration, during December 2023, Calmark Sweden AB, a firm specializing in medical diagnostic biotechnology headquartered in Israel, entered into an agreement granting Techno Orbits exclusive rights to distribute Calmark’s bilirubin test, specifically formulated for neonates, across Saudi Arabia. Techno Orbits is now tasked with managing the sales and distribution activities, utilizing its established infrastructure and connections, notably those with the nation’s Ministry of Health. The objective of this collaboration is to expedite the launch of Calmark’s bilirubin assessment tool into the Saudi Arabian region, with the governmental regulatory sign-off anticipated within a time frame spanning three to six months.

Who Are The Prominent Global Companies Shaping The Bilirubin Blood Test Market?

Major companies operating in the bilirubin blood test market are F.Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Koninklijke Philips N.V., Mindray Medical International Limited, Beckman Coulter Inc., Drägerwerk AG and Co. KGaA, Sysmex Corporation, Bio-Rad Laboratories Inc., Konica Minolta Inc., Instrumentation Laboratory LLC, Randox Laboratories Ltd., Ortho Clinical Diagnostics Inc., Natus Medical Incorporated, Nova Biomedical, Advanced Instruments LLC, Helmer Scientific Inc., Reichert Technologies Inc., Rousselet Robatel SAS, Labnet International Inc., AVI Healthcare Pvt. Ltd., Ginevri S.p.A.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/bilirubin-blood-test-global-market-report

Which Region Currently Holds The Largest Share Of The Bilirubin Blood Test Market?

North America was the largest region in the bilirubin blood test market in 2024. The regions covered in the bilirubin blood test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Bilirubin Blood Test Market Report:

https://www.thebusinessresearchcompany.com/customise?id=18522&type=smp

Browse Through More Reports Similar to the Global Bilirubin Blood Test Market 2025, By The Business Research Company

Anemia And Other Blood Disorder Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/anemia-and-other-blood-disorder-drugs-global-market-report

Blood Transfusion Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report

Stem Cell Cord Blood Banking Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/stem-cell-cord-blood-banking-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Estimated Market Size of the Bilirubin Blood Test Market In 2029?

In the past few years, there has been notable growth in the market size of the bilirubin blood test. It is projected to surge from $1.37 billion in 2024 to $1.47 billion in 2025, showcasing a compound annual growth rate (CAGR) of 7.7%. This remarkable growth during the historic period has been driven by several factors. These include a rise in the occurrence of liver ailments, advancements in neonatal care and technology, growing awareness about health, improvements in healthcare infrastructure, the implementation of regulatory approvals and guidelines, and a heightened preference for point-of-care testing.

What Growth Rate Is Forecasted for the Bilirubin Blood Test Market by 2029?

The market size for bilirubin blood tests is projected to experience significant growth in the coming years, reaching $1.96 billion in 2029 with a compound annual growth rate (CAGR) of 7.5%. The anticipated growth during this forecast period can be linked to factors such as an increased need for early diagnosis, the expansion of diagnostic labs, a higher occurrence of chronic illnesses, the growth of emerging markets, incorporation of advanced analytics, and surge in research funding. The forecast period will also see major trends such as the development of non-invasive test methods, amalgamation with digital health solutions, advancement in home testing kits, improved accuracy and speed of tests, personalizing medicine methods, intelligent diagnostic devices, and the evolution of portable devices.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18522&type=smp

Which Key Companies Are Shaping the Future of the Bilirubin Blood Test Market?

Major companies operating in the bilirubin blood test market are F.Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Koninklijke Philips N.V., Mindray Medical International Limited, Beckman Coulter Inc., Drägerwerk AG and Co. KGaA, Sysmex Corporation, Bio-Rad Laboratories Inc., Konica Minolta Inc., Instrumentation Laboratory LLC, Randox Laboratories Ltd., Ortho Clinical Diagnostics Inc., Natus Medical Incorporated, Nova Biomedical, Advanced Instruments LLC, Helmer Scientific Inc., Reichert Technologies Inc., Rousselet Robatel SAS, Labnet International Inc., AVI Healthcare Pvt. Ltd., Ginevri S.p.A.

Which Factors Are Driving Demand in the Bilirubin Blood Test Industry?

The bilirubin blood test market is set to expand due to the rising occurrence of liver diseases. These diseases, which impede the proper functioning of the liver, may occur due to various factors such as infections, overconsumption of alcohol, or metabolic disorders. The escalating count of liver disease incidents is largely attributed to the increasing rates of obesity, excessive alcohol intake, viral infections, and unhealthy lifestyle choices, all of which collectively cause liver dysfunction and damage. Elevated levels of bilirubin in the body often signal liver disease, and bilirubin blood tests are crucial in diagnosing and monitoring liver function. This provides vital information about the patients’ health, assisting healthcare providers in effectively managing and treating liver-related illnesses. For instance, data from the European Centre for Disease Prevention and Control, a government health agency based in Sweden, recorded 28,855 cases of hepatitis B virus (HBV) infection across 30 EU/EEA Member States in April 2024. This indicates a significant increase of 78% compared to 16,187 cases in 2021. Moreover, the case count in 2022 reached up to 28,420, representing a crude rate of 8.5 cases per 100,000 people. Therefore, the increased cases of liver diseases are fuelling the demand for bilirubin blood test in the market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=18522&type=smp

How Is the Bilirubin Blood Test Market Segmented by Several Divisions?

The bilirubin blood test market covered in this report is segmented –

1) By Test Type: Total Serum Bilirubin Test, Indirect Or Unconjugated Bilirubin Test, Direct Or Conjugated Bilirubin Test

2) By Age Group: Adults, Pediatrics, Infants

3) By Application: Hospital, Clinic, Other Applications

Subsegments:

1) By Total Serum Bilirubin Test: Routine Screening, Liver Function Assessment, Newborn Jaundice Detection

2) By Indirect Or Unconjugated Bilirubin Test: Hemolytic Anemia Diagnosis, Gilbert’s Syndrome Detection, Monitoring For Preliver Conditions

3) By Direct Or Conjugated Bilirubin Test: Bile Duct Obstruction Diagnosis, Hepatitis And Liver Disease Monitoring, Post-Liver Condition Assessment

What are the Emerging Market Trends Driving the Growth of the Bilirubin Blood Test Industry?

Key players in the bilirubin blood test market are embracing strategies of partnerships to broaden their influence and improve their service capabilities. A strategic partnership typically suggests a synergistic relationship between two or more firms where a union of resources, skills, and the collaborative effort towards common targets or aims is achieved. For example, in December 2023, Calmark Sweden AB, a company offering medical diagnostic biotech solutions based in Israel, formally entered an exclusive distribution partnership with Techno Orbits in Saudi Arabia for the distribution of Calmark’s newborn biilirubin test. Techno Orbits will oversee the product’s distribution and sales, utilising its existing networks and connections, including those with the Ministry of Health. The goal of this partnership is to pave the way for Calmark’s bilirubin test in the Saudi market, wherein regulatory registration is projected to occur within a timeline of 3 to 6 months.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/bilirubin-blood-test-global-market-report

Which Regions Are Driving Growth in the Bilirubin Blood Test Market?

North America was the largest region in the bilirubin blood test market in 2024. The regions covered in the bilirubin blood test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18522

This Report Delivers Insight On:

1. How big is the bilirubin blood test market, and how is it changing globally?

2. Who are the major companies in the bilirubin blood test market, and how are they performing?

3. What are the key opportunities and risks in the bilirubin blood test market right now?

4. Which products or customer segments are growing the most in the bilirubin blood test market?

5. What factors are helping or slowing down the growth of the bilirubin blood test market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Industry-Specific Factors Are Fueling the Growth of theBilirubin Blood Test Market?

The escalation in liver disease incidents is likely to spur the expansion of the bilirubin blood test market. Liver conditions, which are a collection of various impairments obstructing the normal liver functioning, could stem from diverse reasons like infections, excessive alcohol intake, or metabolic issues. The growth in liver disease cases is linked to the increasing obesity rates, high alcohol consumption levels, viral infections, and poor lifestyle decisions, cumulatively leading to liver malfunction and destruction. Any significant impact on liver disease affects bilirubin readings in the body, rendering bilirubin blood tests as indispensable tools for detecting and tracking liver function. These blood tests offer invaluable findings about patient health and help healthcare practitioners manage and treat conditions related to the liver more efficiently. For example, in April 2024, the European Centre for Disease Prevention and Control, a health agency based in Sweden, documented 28,855 hepatitis B virus (HBV) infection cases across 30 EU/EEA Member States in 2022, a surge of 78% against the 16,187 cases in 2021. Besides, the count of cases in 2022, which lined up to 28,420, stands for a crude rate of 8.5 cases for every 100,000 individuals. Hence, the rise in liver disease incidents is propelling the bilirubin blood test market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18522&type=smp

How Has the Bilirubin Blood Test Market Evolved in Recent Years, and What are the Growth Projections for the Forecast Period?

The market size for bilirubin blood tests has seen robust growth in the past few years. It is forecasted to increase from $1.37 billion in 2024 to $1.47 billion in 2025, with a compound annual growth rate (CAGR) of 7.7%. The substantial growth observed in the historic phase can be accredited to factors such as the rising incidence of liver ailments, progress in neonatal care, technological evolution, increased awareness about health, enhancements in healthcare infrastructure, regulatory approval and recommendations, along with a heightened embrace of point-of-care testing.

Anticipated to witness robust expansion in the coming years, the bilirubin blood test market is projected to elevate to a worth of $1.96 billion by 2029, boasting a compound annual growth rate (CAGR) of 7.5%. This surge during the forecast period can be credited to factors such as the escalating demand for prompt diagnosis, the proliferation of diagnostic laboratories, a surge in chronic disease incidences, burgeoning growth in emerging markets, the incorporation of sophisticated analytics, and amplified research funding. Notable trends expected to be observed include the evolution of non-invasive testing procedures, amalgamation with digital healthcare solutions, breakthroughs in home testing kits, improved speed and precision in tests, individualized medicine strategies, intelligent diagnostic devices, and the design of portable devices.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18522

What Key Market Trends and Innovations Are Shaping the Future of theBilirubin Blood Test Industry?

To extend their capabilities and bolster their service provision, leading entities in the bilirubin blood test market are resorting to strategic alliances. This kind of partnership essentially represents a cooperative link between two or more establishments where their resources, skills and initiatives are pooled to accomplish shared objectives or goals. For instance, Calmark Sweden AB, a medical diagnostic biotechnology company headquartered in Israel, secured an exclusive distributorship accord with Saudi Arabian Techno Orbits in December 2023 for the distribution of its bilirubin test tailored for newborns. The distribution and sales activities of the product will be undertaken by Techno Orbits utilizing its current network and partnerships, including with the Ministry of Health. The ultimate aim of this alliance is to expedite the entry of Calmark’s bilirubin test into Saudi’s market, where it is estimated that the regulatory approval process will last between 3 to 6 months.

Which Companies Are Leading the Charge in Expanding theBilirubin Blood Test Market Growth?

Major companies operating in the bilirubin blood test market are F.Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Koninklijke Philips N.V., Mindray Medical International Limited, Beckman Coulter Inc., Drägerwerk AG and Co. KGaA, Sysmex Corporation, Bio-Rad Laboratories Inc., Konica Minolta Inc., Instrumentation Laboratory LLC, Randox Laboratories Ltd., Ortho Clinical Diagnostics Inc., Natus Medical Incorporated, Nova Biomedical, Advanced Instruments LLC, Helmer Scientific Inc., Reichert Technologies Inc., Rousselet Robatel SAS, Labnet International Inc., AVI Healthcare Pvt. Ltd., Ginevri S.p.A.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/bilirubin-blood-test-global-market-report

How is the Global Bilirubin Blood Test Market Segemented?

The bilirubin blood test market covered in this report is segmented –

1) By Test Type: Total Serum Bilirubin Test, Indirect Or Unconjugated Bilirubin Test, Direct Or Conjugated Bilirubin Test

2) By Age Group: Adults, Pediatrics, Infants

3) By Application: Hospital, Clinic, Other Applications

Subsegments:

1) By Total Serum Bilirubin Test: Routine Screening, Liver Function Assessment, Newborn Jaundice Detection

2) By Indirect Or Unconjugated Bilirubin Test: Hemolytic Anemia Diagnosis, Gilbert’s Syndrome Detection, Monitoring For Preliver Conditions

3) By Direct Or Conjugated Bilirubin Test: Bile Duct Obstruction Diagnosis, Hepatitis And Liver Disease Monitoring, Post-Liver Condition Assessment

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=18522&type=smp

Which Geographics are Influencing the Growth of the Bilirubin Blood Test Market?

North America was the largest region in the bilirubin blood test market in 2024. The regions covered in the bilirubin blood test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Bilirubin Blood Test Market 2025, By The Business Research Company:

Blood And Blood Components Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/blood-and-blood-components-global-market-report

Patient Blood Management Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/patient-blood-management-global-market-report

Anemia And Other Blood Disorder Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/anemia-and-other-blood-disorder-drugs-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: